Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

Share Price Information for Science Sprt (SIS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.75
Bid: 15.50
Ask: 16.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.226%)
Open: 15.75
High: 15.75
Low: 15.75
Prev. Close: 15.75
SIS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

7 Jan 2019 14:00

RNS Number : 4077M
Science in Sport PLC
07 January 2019
 

For immediate release

7 January 2019

 

 

SCIENCE IN SPORT PLC

("SiS" or the "Company")

 

Issue of equity

 

Science in Sport plc (AIM: SIS), a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts, announces that it has applied for 416,667 new ordinary shares of 10 pence each ("New Ordinary Shares") to be admitted to trading on AIM ("Admission").

 

The New Ordinary Shares are being issued as consideration related to sponsorship services. It is expected that dealings in the New Ordinary Shares will commence at 8.00 a.m. on 11 January 2019.

 

Following admission, the Company will have 122,384,470 ordinary shares of 10 pence each ("Ordinary Shares") outstanding, none of which are held in treasury. The figure of 122,384,470 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

For further information:

Science in Sport PLC

+44 (0) 20 7400 3700

Stephen Moon, CEO

 

Elizabeth Lake, CFO

 

 

 

Liberum Capital Limited - NOMAD and Broker

+44 (0) 20 3100 2227

Clayton Bush

 

Chris Clarke

 

 

 

Instinctif Partners

+44 (0) 20 7457 2020

Matthew Smallwood

 

Tom Berger

 

 

Notes for editors

 

About Science in Sport plc

Science in Sport plc is a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts. SiS is a strong brand in the elite athlete community - in the 2016 Rio Olympics, 34 medal-winning athletes or teams used SiS products.

The SiS core product ranges include: SiS GO, comprising energy powders, isotonic gels, energy bars, hydration tablets and shots; SiS REGO, including protein-based recovery powders; SiS Protein, products specifically designed to contribute to athletes' lean muscle mass growth and maintenance; SiS Supplements, comprising BCAA Perform, Creatine, Beta Alanine and L Glutamine; SiS Athlete Health, vitamins and supplements range designed to support and maintain immune function, digestive health and bone health. SiS products are sold in a range of retail channels, including specialist sport retailers, major grocers, high street retailers and e-commerce websites.

SiS is currently the official sports nutrition supplier to professional cycling organisations Team SKY, British Cycling, Cycling Australia, and USA Cycling. SiS is also a partner to British Triathlon and Rock n Roll Marathon Series. Along with supplying over 70 professional English & Scottish League football teams, SiS Sports Nutrition is the partner to the world's most popular football club, Manchester United FC. In addition, Olympians Sir Chris Hoy MBE, Mark Cavendish MBE and Adam Peaty MBE are Brand Ambassadors.

SiS was founded in 1992 and is headquartered in Hatton Garden, London. Its manufacturing facility is in Nelson, Lancashire.

SiS shares are traded on the AIM market of the London Stock Exchange under the ticker symbol SIS.

About PhD

PhD is a UK-headquartered premium protein brand. Since being founded by Jason Rickaby and Mark Bowering in 2005, PhD has developed into one of the UK's leading protein brands with a reputation for high quality and innovative products aimed at sports enthusiasts and gym lifestyle consumers.

It has c.24 employees and an experienced management team that has a track record of delivering consistent revenue growth and profitability. For the year ended August 2018, PhD reported revenues of £20.8 million and adjusted EBITDA of £2.8 million.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEXDLFBKFFEBBZ
Date   Source Headline
6th Mar 20247:00 amRNSTrading Update
5th Jan 20247:00 amRNSDirector/PDMR Shareholding
5th Jan 20247:00 amRNSNotification of Major Holdings
29th Dec 202311:20 amRNSIssue of Equity and Total Voting Rights
19th Oct 20237:00 amRNSDirectorate Change
16th Oct 20237:00 amRNSBoard Changes
28th Sep 202310:30 amRNSInterim Results - Replacement
28th Sep 20237:00 amRNSAppointment of Non Exec Chairman
28th Sep 20237:00 amRNSInterim Results
28th Jul 20232:58 pmRNSResult of Annual General Meeting
28th Jul 20237:00 amRNSBoard changes
10th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20233:49 pmRNSTR-1: Notification of Major Holdings
5th Jul 20237:00 amRNSBoard Change and Notice of AGM
4th Jul 20237:30 amRNSRestoration - Science in Sport PLC
4th Jul 20237:00 amRNSRestoration of Trading & Posting of Annual Report
3rd Jul 20237:30 amRNSSuspension - Science In Sport Plc
3rd Jul 20237:00 amRNSTemporary Suspension
29th Jun 202310:38 amRNSReplacement RNS - Preliminary Results
29th Jun 20237:00 amRNSFinal results
28th Jun 202310:43 amRNSNotification of Major Holdings
23rd Jun 20237:00 amRNSNotice of Final Results
2nd May 20233:33 pmRNSAIM Rule 17 / Schedule 2(g) Update
18th Apr 20237:00 amRNSInvestor Site Visit
13th Apr 202312:23 pmRNSForm 8.3 - Science In Sport Plc
13th Apr 202312:06 pmRNSForm 8.3 - Science in Sport PLC
13th Apr 20238:34 amRNSForm 8.5 (EPT/RI)
13th Apr 20237:00 amRNSConclusion of Strategic Review and Trading Update
12th Apr 20239:06 amRNSForm 8.5 (EPT/RI)
11th Apr 20232:54 pmRNSForm 8.3 - Science In Sport Plc
11th Apr 202312:17 pmRNSForm 8.3 - Science in Sport PLC
11th Apr 20239:22 amRNSForm 8.5 (EPT/RI)
11th Apr 20237:00 amRNSForm 8.3 - Science in Sport PLC
6th Apr 20236:17 pmRNSForm 8.3 - SCIENCE IN SPORT PLC
6th Apr 20232:52 pmRNSForm 8.3 - [Science in Sport plc]
5th Apr 20238:22 amRNSForm 8.5 (EPT/RI)
3rd Apr 20232:29 pmRNSForm 8.3 - [Science in Sport plc]
3rd Apr 20239:20 amRNSForm 8.5 (EPT/RI)
30th Mar 20238:50 amRNSForm 8.5 (EPT/RI)
29th Mar 202311:58 amRNSForm 8.3 - Science in Sport Plc
29th Mar 20238:42 amRNSForm 8.5 (EPT/RI)
28th Mar 20239:57 amRNSForm 8.3 - Science in Sport Plc
28th Mar 20239:52 amRNSForm 8.5 (EPT/RI) - Science in Sport PLC
27th Mar 202312:31 pmRNSForm 8.3 - Science in Sport PLC
27th Mar 202312:29 pmRNSForm 8.3 - Science in Sport Plc
23rd Mar 202311:01 amRNSForm 8.3 - Science in Sport PLC
23rd Mar 202310:54 amRNSForm 8.3 - Science in Sport PLC
23rd Mar 20238:43 amRNSForm 8.5 (EPT/RI)
22nd Mar 20235:55 pmRNSForm 8.3 - Science in Sport PLC
22nd Mar 20231:15 pmRNSForm 8.3 - Science in Sport plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.